| scholarly article | Q13442814 |
| P50 | author | Christian T. Bautista | Q39749039 |
| P2093 | author name string | Perez J | |
| Taylor DN | |||
| Echeverria P | |||
| Meza R | |||
| Sanchez JL | |||
| Gilman R | |||
| Sadoff J | |||
| Bégué RE | |||
| Puga R | |||
| Cárdenas V | |||
| Gaillour A | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Peru | Q419 |
| cholera | Q12090 | ||
| P304 | page(s) | 1667-1673 | |
| P577 | publication date | 2000-05-15 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru | |
| P478 | volume | 181 |
| Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
| Q55890255 | Cholera |
| Q35232735 | Cholera toxin B: one subunit with many pharmaceutical applications |
| Q26823170 | Critical analysis of compositions and protective efficacies of oral killed cholera vaccines |
| Q92264663 | Current and future cholera vaccines |
| Q35261144 | Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis |
| Q44235991 | Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial |
| Q36444089 | Enteric infections and the vaccines to counter them: future directions |
| Q38979270 | Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine |
| Q33552968 | Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti |
| Q35913540 | Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells |
| Q34087755 | Killed oral cholera vaccines: history, development and implementation challenges |
| Q33927450 | Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care |
| Q35940653 | Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh |
| Q40695423 | New developments in the understanding of cholera |
| Q37953796 | New-generation vaccines against cholera |
| Q36489754 | Oral cholera vaccines: use in clinical practice |
| Q30401927 | Oral vaccines against cholera |
| Q24235775 | Oral vaccines for preventing cholera |
| Q36690265 | Present and future cholera vaccines |
| Q39448785 | Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis |
| Q79268993 | Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003 |
| Q81434561 | Response to "questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003" Vaccine 2007;25(8):1353-4 |
| Q35547754 | Review of oral cholera vaccines: efficacy in young children |
| Q57490842 | The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination |
| Q27004488 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae |
Search more.